Monday, 10 June 2013

Prevenar

Prevenar 13

Prevenar 13

Prevenar 13

Generic name/Active ingredient: Pneumococcal polysaccharide conjugate vaccine (adsorbed, 13-valent)
Trade name: Prevenar 13
Dosage form: Injection
Drug classification: Pneumococcal bacterial vaccines
Legal classification: POM
Company: Pfizer
Commonly used for: Active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants and children from 6 weeks to 5 years prior to the 6th birthday